AeroGrow International 10-Q 11 Feb 14 2014 Q3 Quarterly report Financial data

Document_And_Entity_Informatio

Document And Entity Information	9 Months Ended
	Dec. 31, 2013	Feb. 07, 2014
Document and Entity Information [Abstract]	'	'
Entity Registrant Name	'AeroGrow International, Inc.	'
Document Type	'10-Q	'
Current Fiscal Year End Date	'--03-31	'
Entity Common Stock, Shares Outstanding	'	5,906,634
Amendment Flag	'false	'
Entity Central Index Key	'0001316644	'
Entity Current Reporting Status	'Yes	'
Entity Voluntary Filers	'No	'
Entity Filer Category	'Smaller Reporting Company	'
Entity Well-known Seasoned Issuer	'No	'
Document Period End Date	31-Dec-13	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q3	'

CONDENSED_BALANCE_SHEETS

CONDENSED BALANCE SHEETS (USD $)	Dec. 31, 2013	Mar. 31, 2013
In Thousands, unless otherwise specified
Current assets	'	'
Cash	$1,274	$525
Restricted cash	15	42
Accounts receivable, net of allowance for doubtful accounts of $13 and $1 at December 31, 2013 and March 31, 2013, respectively	1,473	173
Other receivables	131	169
Inventory	1,598	1,229
Prepaid expenses and other	223	205
Total current assets	4,714	2,343
Property and equipment, net of accumulated depreciation of $2,982 and $2,869 at December 31, 2013 and March 31, 2013, respectively	335	266
Other assets	'	'
Intangible assets, net of $0 and $135 of accumulated amortization at December 31, 2013 and March 31, 2013, respectively	2	195
Deposits	146	145
Deferred debt issuance costs, net of accumulated amortization of $271 and $255 at December 31, 2013 and March 31, 2013, respectively	7	23
Total other assets	155	363
Total assets	5,204	2,972
Current liabilities	'	'
Accounts payable	756	379
Accrued expenses	809	292
Customer deposits	0	157
Deferred rent	4	6
Notes payable	0	518
Notes payable – related party	0	122
Current portion – long term debt	112	900
Derivative warrant liability	595	'
Debt associated with sale of IP	271	0
Total current liabilities	2,547	2,374
Long term debt	0	1,169
Total liabilities	2,547	3,543
Commitments and contingencies	'	'
Stockholders' equity (deficit)	'	'
Preferred stock, $.001 par value, 20,000,000 shares authorized, 2,649,007 and no shares issued and outstanding at December 31, 2013 and March 31, 2013, respectively	3	0
Common stock, $.001 par value, 750,000,000 shares authorized, 5,906,635 and 5,904,877 shares issued and outstanding at December 31, 2013 and March 31, 2013, respectively	6	6
Additional paid-in capital	79,167	75,427
Stock dividend to be distributed	367	0
Accumulated deficit	-76,886	-76,004
Total stockholders' equity (deficit)	2,657	-571
Total liabilities and stockholders' equity (deficit)	$5,204	$2,972

CONDENSED_BALANCE_SHEETS_Paren

CONDENSED BALANCE SHEETS (Parentheticals) (USD $)	Dec. 31, 2013	Mar. 31, 2013
In Thousands, except Share data, unless otherwise specified
Allowance for doubtful accounts (in Dollars)	$13	$1
Accumulated depreciation (in Dollars)	2,982	2,869
Accumulated amortization of intangible assets (in Dollars)	0	135
Accumulated amortization of deferred debt issuance costs (in Dollars)	$271	$255
Preferred stock, par value (in Dollars per share)	$0.00	$0.00
Preferred stock, shares authorized (in Shares)	20,000,000	20,000,000
Preferred stock, shares issued (in Shares)	2,649,007	0
Preferred stock, shares outstanding (in Shares)	2,649,007	0
Common stock, par value (in Dollars per share)	$0.00	$0.00
Common stock, shares authorized (in Shares)	750,000,000	750,000,000
Common stock, shares issued (in Shares)	5,906,635	5,904,877
Common stock, shares outstanding (in Shares)	5,906,635	5,904,877

CONDENSED_STATEMENTS_OF_OPERAT

CONDENSED STATEMENTS OF OPERATIONS (Unaudited) (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Net revenue	$4,968	$2,972	$6,767	$5,533
Cost of revenue	2,867	1,665	3,977	2,905
Gross profit	2,101	1,307	2,790	2,628
Operating expenses	'	'	'	'
Research and development	17	94	72	302
Sales and marketing	1,262	882	2,127	1,765
General and administrative	451	390	1,231	1,407
Total operating expenses	1,730	1,366	3,430	3,474
Profit (loss) from operations	371	-59	-640	-846
Other (income) expense, net	'	'	'	'
Fair value changes in derivative warrant liability	18	0	31	0
Interest expense	14	228	65	441
Interest expense – related party	2	9	8	25
Debt conversion cost	0	0	0	6,648
Other expense (income)	35	1	-498	-97
Total other expense, net	69	238	-394	7,017
Net income (loss)	302	-297	-246	-7,863
Less: Deemed dividend on convertible preferred stock	0	0	-268	0
Less: Preferred stock dividend	-226	0	-367	0
Net income (loss) attributable to common shareholders	$76	($297)	($881)	($7,863)
Net income (loss) per share, basic (in Dollars per share)	$0.01	($0.05)	($0.10)	($1.35)
Net income (loss) per share, diluted (in Dollars per share)	$0.01	($0.05)	($0.10)	($1.35)
Weighted average number of common shares outstanding, basic (in Shares)	5,906	5,905	5,905	5,826
Weighted average number of common shares outstanding, diluted (in Shares)	5,992	5,905	5,905	5,826

CONDENSED_STATEMENTS_OF_CASH_F

CONDENSED STATEMENTS OF CASH FLOWS (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Cash flows from operating activities:	'	'
Net (loss)	($246)	($7,863)
Adjustments to reconcile net (loss) to cash (used) provided by operations:	'	'
Issuance of common stock and options under equity compensation plans	176	167
Issuance of common stock warrants	18	0
Depreciation and amortization expense	113	123
Bad debt expense	13	2
Fair value remeasurement of derivative warrant liability	31	0
Accretion of debt associated with sale of intellectual property	-35	0
Gain on the forgiveness of debt	-489	0
Debt conversion costs associated with inducement	0	3,462
Amortization of debt issuance costs	16	988
Amortization of convertible debentures, beneficial conversion feature	0	1,067
Amortization of convertible debentures, beneficial conversion feature – related party	0	189
Interest expense from warrants issued with convertible debentures	0	955
Interest expense from warrants issued with convertible debentures – related party	0	187
Change in operating assets and liabilities:	'	'
(Increase) in accounts receivable	-1,313	-271
Decrease in other receivable	38	52
(Increase) in inventory	-606	-182
(Increase) decrease in other current assets	-18	151
Increase in accounts payable	377	72
Increase in accrued expenses	517	148
Increase in accrued interest	49	116
Increase in accrued interest-related party	8	22
(Decrease) increase in customer deposits	-157	149
(Decrease) in deferred rent	-2	0
Net cash (used) provided by operating activities	-1,510	-466
Cash flows from investing activities:	'	'
Decrease in restricted cash	27	1
Purchases of equipment	-184	-292
Patent expenses	0	-10
Proceeds from the sale of intellectual property	500	0
Net cash provided (used) by investing activities	343	-301
Cash flows from financing activities:	'	'
(Increase) in prepaid debt issuance costs	0	-46
Proceeds from notes payable, net	0	1,041
Proceeds from notes payable – related party, net	0	245
Repayments of notes payable	-563	-796
Repayments of notes payable – related party	-123	-272
Repayments of long term debt borrowings	-1,243	-251
Proceeds from the exercise of stock options	2	0
Proceeds from the issuance of preferred stock	4,000	0
Payments for offering costs of preferred stock	-157	0
Proceeds from the exercise and issuance of warrants	0	1,181
Net cash provided by financing activities	1,916	1,102
Net increase in cash	749	335
Cash, beginning of period	525	502
Cash, end of period	1,274	837
Interest	41	119
Income taxes	0	0
Supplemental disclosure of non-cash investing and financing activities:	'	'
Deemed dividend on convertible preferred stock	268	0
Decrease of inventory associated with debt settlement	237	0
Fair value of derivative warrant liability	564	0
Fair value of warrant issue to placement agent	108	0
Debt associated with sale of intellectual property	297	0
Dividends accrued on convertible preferred stock	367	0
Decrease of debt associated with inventory consumption	0	242
Issuance of common stock in accordance with credit card note	0	177
Conversion of accrued expenses to common stock	0	28
Conversion of Note Payable to Common Stock [Member]	'	'
Supplemental disclosure of non-cash investing and financing activities:	'	'
Conversion of Debt to Common Stock	0	212
Conversion of Note Payable - Related Party to Common Stock [Member]	'	'
Supplemental disclosure of non-cash investing and financing activities:	'	'
Conversion of Debt to Common Stock	0	129
Conversion of convertible note to common stock [Member]	'	'
Supplemental disclosure of non-cash investing and financing activities:	'	'
Conversion of Debt to Common Stock	0	5,718
Conversion of convertible note accrued interest to common stock [Member]	'	'
Supplemental disclosure of non-cash investing and financing activities:	'	'
Conversion of Debt to Common Stock	0	545
Conversion of convertible note-related party to common stock [Member]	'	'
Supplemental disclosure of non-cash investing and financing activities:	'	'
Conversion of Debt to Common Stock	0	1,079
Conversion of convertible note-related party accrued interest to common stock [Member]	'	'
Supplemental disclosure of non-cash investing and financing activities:	'	'
Conversion of Debt to Common Stock	$0	$103

1_Description_of_the_Business

1. Description of the Business	9 Months Ended
	Dec. 31, 2013
Disclosure Text Block [Abstract]	'
Basis of Accounting [Text Block]	'
	1.    Description of the Business
	AeroGrow International, Inc. (the “Company," “we,” “AeroGrow,” or “our”) was formed as a Nevada corporation in March 2002. The Company’s principal business is developing, marketing, and distributing advanced indoor aeroponic garden systems designed and priced to appeal to the consumer gardening, cooking and small indoor appliance markets worldwide.   The Company manufactures, distributes and markets six different models of its AeroGarden systems in multiple colors, as well as over 40 varieties of seed pod kits and a full line of accessory products through multiple channels including retail distribution, catalogue and direct-to-consumer sales primarily in the United States and Canada, as well as selected countries in Europe, Asia and Australia.

2_Liquidity_and_Basis_of_Prese

2. Liquidity and Basis of Presentation	9 Months Ended
	Dec. 31, 2013
Disclosure Text Block [Abstract]	'
Basis of Presentation and Significant Accounting Policies [Text Block]	'
	2.    Liquidity and Basis of Presentation
	Interim Financial Information
	The unaudited interim financial statements of the Company included herein have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”) for interim reporting including the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. These condensed statements do not include all disclosures required by accounting principles generally accepted in the United States of America (“U.S. GAAP”) for annual audited financial statements and should be read in conjunction with the Company’s audited financial statements and related notes included in the Company’s Annual Report on Form 10-K for the year ended March 31, 2013, as filed with the SEC on July 1, 2013.
	In the opinion of management, the accompanying unaudited interim financial statements reflect all adjustments, including normal recurring adjustments, necessary to present fairly the financial position of the Company at December 31, 2013, the results of operations for the three- and nine–month periods ended December 31, 2013 and 2012, and the cash flows for the nine–month periods ended December 31, 2013 and 2012. The results of operations for the three and nine months ended December 31, 2013 are not necessarily indicative of the expected results of operations for the full year or any future period. In this regard, the Company’s business is highly seasonal, with approximately 49.3% of revenues in the fiscal year ended March 31, 2013 (“Fiscal 2013”) occurring in the four consecutive calendar months of October through January.  Furthermore, during the nine-month period ended December 31, 2013, the Company has curtailed sales and incurred additional product and marketing expenses while it cobranded inventory and advertising materials with the Scotts Miracle-Gro trade name.  The balance sheet as of March 31, 2013 is derived from the Company’s audited financial statements.
	Sources of funding to meet prospective cash requirements include the Company’s existing cash balances, cash flow from operations, and borrowings under the Company’s debt arrangements.  We may need to seek additional capital, however, to provide a cash reserve against contingencies, address the seasonal nature of our working capital needs, and to enable us to invest further in trying to increase the scale of our business.  There can be no assurance we will be able to raise this additional capital.
	Significant Accounting Policies
	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.  It is reasonably possible that a change in the Company’s estimates will occur in the near term.
	Net Income (Loss) per Share of Common Stock
	The Company computes net income (loss) per share of common stock in accordance with Accounting Standards Codification (“ASC”) 260.  ASC 260 requires companies with complex capital structures to present basic and diluted earnings per share (“EPS”).  Basic EPS is measured as the income or loss available to common stockholders divided by the weighted average shares of common stock outstanding for the period. Diluted EPS is similar to basic EPS, but presents the dilutive effect on a per share basis of potential common stock (e.g., convertible securities, options, and warrants) as if they had been converted at the beginning of the periods presented. Potential shares of common stock that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS.
	The following table presents the computation of basic and diluted net income per share for the three months ended December 31, 2013 (in thousands, except per share amounts):
		31-Dec-13
	Net income available to common shareholders	$	76
	Basic:
	Weighted-average shares outstanding		5,906
	Basic net income per share	$	0.01
	Diluted:
	Weighted-average shares outstanding		5,906
	Add: Dilutive potential shares-Stock options		86
	Weighted-average shares used in computing diluted net income per share		5,992
	Diluted net income per share	$	0.01
	Employee stock options to purchase approximately 13,000 shares were outstanding and approximately 528,000 warrants to purchase common stock were outstanding but were not included in the computation of diluted net income per share because the effect of including such shares would have been antidilutive in the periods presented.
	Reclassifications
	Certain prior year amounts have been reclassified to conform to current year presentation.
	Concentrations of Risk
	ASC 825-10-50-20 requires disclosure of significant concentrations of credit risk regardless of the degree of such risk.  Financial instruments with significant credit risk include cash deposits.  The amount on deposit with one financial institution exceeded the $250,000 federally insured limit as of December 31, 2013.  However, management believes that the financial institution is financially sound and the risk of loss is minimal.
	Customers:
	For the three months ended December 31, 2013, two customers, Amazon.com and Costco, represented 39.2% and 10.7% of the Company’s net revenue, respectively. For the three months ended December 31, 2012, two customers, Amazon.com and Canadian Tire Corporation, represented 19.3% and 12.8% of the Company’s net revenue, respectively. For the nine months ended December 31, 2013, two customers, Amazon.com and Costco, represented 33.6% and 7.9% of the Company’s net revenue, respectively. For the nine months ended December 31, 2012, two customers, Amazon.com and Canadian Tire Corporation, represented 10.4% and 7.9% of the Company’s net revenue, respectively.
	Suppliers:
	For the three months ended December 31, 2013, the Company purchased inventories and other inventory-related items from three suppliers totaling $839,000, $707,000, and $205,000, representing 29.3%, 24.7%, and 7.2% of cost of revenue, respectively. For the three months ended December 31, 2012, the Company purchased inventories and other inventory-related items from two suppliers totaling $263,000 and $254,000, representing 15.8% and 15.3% of cost of revenue, respectively. For the nine months ended December 31, 2013, the Company purchased inventories and other inventory-related items from three suppliers totaling $1.4 million, $992,000, and $270,000 representing 34.4%, 24.9%, and 6.8%, of cost of revenue, respectively. For the nine months ended December 31, 2012, the Company purchased inventories and other inventory-related items from four suppliers totaling $587,000, $433,000, $392,000, and $334,000 representing 20.2%, 14.9%, 13.5%, and 11.5% of cost of revenue, respectively.
	The Company’s primary contract manufacturers are located in China.  As a result, the Company may be subject to political, currency, regulatory and weather/natural disaster risks.  Although the Company believes alternate sources of manufacturing could be obtained, these risks could have an adverse impact on operations.
	Accounts Receivable:
	As of December 31, 2013, the Company had two customers, Amazon.com and Costco, that represented 62.3% and 23.6% of the Company’s outstanding accounts receivable, respectively.  As of March 31, 2013, the Company one customer, Amazon.com  who represented 61.2% of outstanding accounts receivable.  The Company believes that all receivables from these customers are collectible.
	Fair Value of Financial Instruments
	The Company follows the guidance in ASC 820, Fair Value Measurements and Disclosures (“ASC 820”), as it relates to the fair value of its financial assets and liabilities. ASC 820 provides for a standard definition of fair value to be used in new and existing pronouncements. This guidance requires disclosure of fair value information about certain financial instruments (insurance contracts, real estate, goodwill and taxes are excluded) for which it is practicable to estimate such values, whether or not these instruments are included in the balance sheet at fair value. The fair values presented for certain financial instruments are estimates which, in many cases, may differ significantly from the amounts that could be realized upon immediate liquidation.
	Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability, i.e., exit price, in an orderly transaction between market participants.  ASC 820 also provides a hierarchy for determining fair value, which emphasizes the use of observable market data whenever available. The three broad levels defined by the hierarchy are as follows, with the highest priority given to Level 1 as these are the most reliable, and the lowest priority given to Level 3.
	Level 1 – Quoted prices in active markets for identical assets.
	Level 2 – Quoted prices for similar assets in active markets, quoted prices for identical or similar assets in markets that are not active, or other inputs that are observable or can be corroborated by observable market data, including model-derived valuations.
	Level 3 – Unobservable inputs that are supported by little or no market activity.
	The carrying value of financial instruments including receivables and accounts payable, approximates their fair value at December 31, 2013 and March 31, 2013 due to the relatively short-term nature of these instruments. As of December 31, 2013 and March 31, 2013, the fair value of the Company's debt, notes payable, and sale of intellectual property liability using Level 3 inputs was estimated using the discounted cash flow method, which is based on the future expected cash flows, discounted to their present values, using a discount rate of 15%.
	In conjunction with a Securities Purchase Agreement and strategic alliance with a wholly owned subsidiary of The Scotts Miracle-Gro Company (collectively with the subsidiary, “Scotts Miracle-Gro”) on April 22, 2013, the Company issued a warrant that entitles, but does not obligate, Scotts Miracle-Gro to purchase a number of shares of common stock that, on a fully diluted basis, constitute 80% of the Company’s outstanding capital stock. This warrant was accounted for as a liability at its estimated fair value. The Company calculated the fair value of the warrant during the quarter ended December 31, 2013 using a multiple based valuation model.  As of December 31, 2013, the Company measured the warrant at fair value and will continue to do so on a quarterly basis.  As of March 31, 2013, the Company did not have any financial assets or liabilities that were measured at fair value on a recurring basis subsequent to initial recognition.
		31-Dec-13				31-Mar-13
		(in thousands)				(in thousands)
		Fair Value		Carry Value		Fair Value		Carry Value
	Liabilities
	Notes payable	$	-	$	-	$	610	$	641
	Sale of intellectual property liability		178		271		-		-
	Derivative warrant liability		595		595		-		-
	Long-term debt		109		112		1,726		2,068
	Total	$	882	$	978	$	2,336	$	2,709
	Accounts Receivable and Allowance for Doubtful Accounts
	The Company sells its products to retailers and consumers. Consumer transactions are primarily paid by credit card.  Retailer sales terms vary by customer, but generally range from net 30 days to net 60 days.  Accounts receivable are reported at net realizable value and net of the allowance for doubtful accounts. The Company uses the allowance method to account for uncollectible accounts receivable. The Company's allowance estimate is based on a review of the current status of trade accounts receivable, which resulted in an allowance of $13,000 and $1,000 at December 31, 2013 and March 31, 2013, respectively.
	Other Receivables
	In conjunction with the Company’s processing of credit card transactions for its direct-to-consumer sales activities and as security with respect to the Company’s performance for credit card refunds and charge backs, the Company is required to maintain a cash reserve with Litle and Company, the Company’s credit card processor. This reserve is equal to 5% of the credit card sales processed during the previous six months. As of December 31, 2013 and March 31, 2013, the balance in this reserve account was $131,000 and $169,000, respectively.
	Advertising and Production Costs
	The Company expenses all production costs related to advertising, including print, television, and radio advertisements when the advertisement has been broadcast or otherwise distributed.  The Company records media costs related to its direct-to-consumer advertisements, inclusive of postage and printing costs incurred in conjunction with mailings of direct-response catalogues, and related direct-response advertising costs, in accordance with ASC 340-20-Reporting on Advertising Costs.  As prescribed by ASC 340-20-25, direct-to-consumer advertising costs incurred are reported as assets and are amortized over the estimated period of the benefits, based on the proportion of current period revenue from the advertisement to probable future revenue.
	As the Company has re-entered the retail distribution channel, the Company has expanded its advertising to online gateway and portal advertising, as well as placement in third party catalogues.
	Advertising expense for the three and nine months ended December 31, 2013 and December 31, 2012, were as follows:
		Three Months Ended				Nine Months Ended
		December 31,				December 31,
		(in thousands)				(in thousands)
		2013		2012		2013		2012
	Direct-to-consumer	$	391	$	534	$	506	$	825
Retail		390		1		393		1
Total advertising expense	$	781	$	535	$	899	$	826
As of December 31, 2013 and March 31, 2013, the Company deferred $6,000 and $4,000, respectively, related to such media and advertising costs.
	December 31,		March 31,
	2013		2013
	(in thousands)		(in thousands)
Deferred advertising and media	$	6	$	4
Inventory
Inventories are valued at the lower of cost, determined by the first-in, first-out method, or market.  Included in inventory costs where the Company is the manufacturer are raw materials, labor, and manufacturing overhead. The Company records the raw materials at delivered cost. Standard labor and manufacturing overhead costs are applied to the finished goods based on normal production capacity.  A majority of the Company’s products are manufactured overseas and are recorded at cost.
	December 31,		March 31,
	2013		2013
	(in thousands)		(in thousands)
Finished goods	$	1,124	$	606
Raw materials		474		623
	$	1,598	$	1,229
The Company determines an inventory obsolescence reserve based on management’s historical experience and establishes reserves against inventory according to the age of the product. As of December 31, 2013 and March 31, 2013, the Company had reserved $332,000 for inventory obsolescence.
Revenue Recognition
The Company recognizes revenue from product sales, net of estimated returns, when persuasive evidence of a sale exists: that is, a product is shipped under an agreement with a customer; risk of loss and title has passed to the customer; the fee is fixed or determinable; and collection of the resulting receivable is reasonably assured.
The Company records estimated reductions to revenue for customer and distributor programs and incentive offerings, including promotions, rebates, and other volume-based incentives.  Certain incentive programs require the Company to estimate based on industry experience the number of customers who will actually redeem the incentive. As of December 31, 2013 and March 31, 2013, the Company had accrued $236,000 and $43,000, respectively, as its estimate for the foregoing deductions and allowances.
Warranty and Return Reserves
The Company records warranty liabilities at the time of sale for the estimated costs that may be incurred under its basic warranty program. The specific warranty terms and conditions vary depending upon the product sold, but generally include technical support, repair parts, and labor for periods up to one year. Factors that affect the Company’s warranty liability include the number of installed units currently under warranty, historical and anticipated rates of warranty claims on those units, and cost per claim to satisfy the Company’s warranty obligation.  Based upon the foregoing, the Company has recorded a reserve for potential future warranty costs of $14,000 and $10,000 as of December 31, 2013 and March 31, 2013, respectively.
The Company reserves for known and potential returns from customers and associated refunds or credits related to such returns based upon historical experience. In certain cases, retailer customers are provided a fixed allowance, usually in the 1% to 2% range, to cover returned goods and this allowance is deducted from payments made to us by such customers. As of December 31, 2013 and March 31, 2013, the Company has recorded a reserve for customer returns of $80,000 and $27,000, respectively.
Recently Issued Accounting Pronouncements
In July 2013, the FASB issued ASU 2013-11, “Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists,” which among other things, requires an unrecognized tax benefit, or a portion of an unrecognized tax benefit, to be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward, except as denoted within the ASU. The amendments in this ASU are effective for fiscal years, and interim periods within those years, beginning after December 15, 2013. This new guidance will not have a material impact on our financial statements.

3_Notes_Payable_Long_Term_Debt

3. Notes Payable, Long Term Debt and Current Portion - Long Term Debt	9 Months Ended
	Dec. 31, 2013
Debt Disclosure [Abstract]	'
Debt Disclosure [Text Block]	'
	3.    Notes Payable, Long Term Debt and Current Portion – Long Term Debt
	Refer to the Company’s Annual Report on Form 10-K for the year ended March 31, 2013, as filed with the SEC on July 1, 2013 for a detailed discussion on Notes Payable, Long Term Debt and Current Portion – Long Term Debt.  The following are the changes to our Notes Payable, Long Term Debt and Current Portion – Long Term Debt for the periods presented.
	As of December 31, 2013 and March 31, 2013, the outstanding balance of the Company’s note payable and debt, including accrued interest, is as follows:
		December 31,		March 31,
		2013		2013
		(in thousands)		(in thousands)
	Main Power promissory note	$	-	$	1,704
	First Western Trust term loan		99		323
	Notes Payable –credit card receipts-backed notes		-		640
	Pawnee promissory note		13		42
	Sale of intellectual property liability (see Note 4)		271		-
	Derivative warrant liability (see Note 4)		595		-
	Total debt		978		2,709
	Less notes payable and current portion – long term debt		978		1,540
	Long term debt	$	-	$	1,169
	Main Power Promissory Note
	On June 30, 2009, the Company entered into a Letter Agreement (“Letter Agreement”) with Main Power Electrical Factory, Ltd. (“Main Power”) and executed a Promissory Note.  Pursuant to the terms of the Letter Agreement, Main Power agreed to release the Company from $1.4 million of existing obligations owed by the Company to Main Power in return for the execution of the Promissory Note for the same amount which was amended several times since inception to extend the payment schedule, maturity date and amount owed.   On April 23, 2013, the MainPower Promissory Note outstanding, including all accrued interest, was paid in full for $950,000.
	As of April 23, 2013, the Company had consigned approximately $237,000 of inventory with Main Power, all of which was fully reserved for during the three month period ended June 30, 2013. The inventory reserve combined with the payment in full resulted in a net gain of $489,000, which was recognized as other income and expense for the nine months ended December 31, 2013.
	First Western Trust Term Loan
	On May 21, 2010, the Company, First Western Trust Bank (“FWTB”) and Jack J. Walker, our Chairman, as guarantor, executed a business loan agreement and related promissory note (the “FWTB Term Loan”) for a four-year loan in an initial principal amount of $1.0 million.  The FWTB Term Loan is secured by a lien on our assets and bears interest at a fixed rate of 7.25% per annum.  The Company makes equal monthly payments of principal/interest over the four-year term of the FWTB Term Loan, which has a final maturity date of May 21, 2014.  The terms and conditions of the FWTB Term Loan include limitations on the Company incurring additional debt and paying dividends on our stock without the consent of FWTB.  In the event of a default under the FWTB Term Loan, FWTB has the option to declare the loan immediately due and payable.
	As of December 31, 2013, $99,000 was outstanding under the FWTB Term Loan, including accrued interest, and we were current and in compliance with all terms and conditions.
	Notes Payable – 2012 Credit Card Receipts-Backed Notes
	On September 14, 2012, the Company closed on the private sale of $1.3 million in Series 2012CC 15% secured promissory notes backed by a portion of the Company’s prospective credit card receipts, (the “2012 Credit Card Notes”) and 128,573 shares of common stock (collectively, the “2012 Credit Card Offering”).  Consideration for the 2012 Credit Card Offering comprised $1.3 million in cash.  After deducting $46,000 of placement agent sales commissions (5% on third-party investors, 3% on Company-referred investors and 0% on investments by officers and directors of the Company) and expenses, net cash proceeds to the Company totaled $1.2 million.   In addition, the Company issued 12,858 shares of common stock to the placement agent as additional sales compensation, representing one share of common stock for every 10 shares issued to investors in the 2012 Credit Card Offering.
	The Company used the proceeds from the 2012 Credit Card Offering to invest in advertising and marketing programs to support its direct-to-consumer business, purchase inventory, provide other general working capital, repay $198,000 of the 2011 Credit Card Notes (including accrued interest) and pay commissions and expenses related to the private offering.
	As of December 17, 2013, the remaining balance and accrued interest on the 2012 Credit Card Notes were repaid in full.
	Pawnee Lease Promissory Note
	On November 30, 2011, the Company executed a promissory note (the “Lease Promissory Note”) in the principal amount of $116,000 in favor of Pawnee Properties, LLC (“Pawnee”).  The Lease Promissory Note details the terms and conditions pursuant to which the Company will pay to Pawnee past due rent and building operating expenses related to our headquarters lease.  The Lease Promissory Note carries an interest rate of 6% per annum for the first twelve months, and 8% per annum thereafter.
	As of December 31, 2013, the outstanding balance of the Lease Promissory Note, including accrued interest, was $13,000 and we were current and in compliance with all terms and conditions.
	Debt Associated with Scotts Miracle-Gro Transaction
	On April 22, 2013, the Company issued Series B Convertible Preferred Stock to a wholly-owned subsidiary of Scotts Miracle-Gro.  Pursuant to U.S. GAAP, the Company has classified the warrant as a liability at its estimated fair value.  The derivative warrant liability will be re-measured to fair value, on a recurring basis, at the end of each reporting period until it is exercised or expires.  The valuation techniques used to determine the fair value of the derivative warrant liability and the terms of the warrant are further explained in Note 4.  As of December 31, 2013 the fair value of the warrant was $595,000.
	The Company and Scotts Miracle-Gro also agreed to enter an Intellectual Property Sale Agreement, a Technology License Agreement, a Brand License Agreement, and a Supply Chain Services Agreement.  The Intellectual Property Sale Agreement and the Technology License constitute an agreement of sales of future revenues. Since the Company received cash from Scotts Miracle-Gro and agreed to pay for a defined period a specified percentage of revenue, and because the Company has significant involvement in the generation of its revenue, the excess paid over net book value is classified as debt and is being amortized under the effective interest method.  As of December 31, 2013, $271,000 was recorded as debt on the condensed balance sheets.

4_Scotts_MiracleGro_Transactio

4. Scotts Miracle-Gro Transactions - Convertible Preferred Stock, Warrants and Other Transactions	9 Months Ended
	Dec. 31, 2013
Disclosure Text Block Supplement [Abstract]	'
Preferred Stock [Text Block]	'
	4.    Scotts Miracle-Gro Transactions – Convertible Preferred Stock, Warrants and Other Transactions
	Series B Convertible Preferred Stock and Related Transactions
	On April 22, 2013, the Company entered into a Securities Purchase Agreement with Scotts Miracle-Gro.  Pursuant to the Securities Purchase Agreement, Scotts Miracle-Gro acquired 2.6 million shares of the Company’s Series B Convertible Preferred Stock, par value $0.001 per share (the “Series B Preferred Stock”), and (ii) a warrant to purchase shares of the Company’s common stock (the “Warrant,” as described in greater detail below) for an aggregate purchase price of $4.0 million.  After deducting offering expenses, including commissions and expenses paid to the Company’s advisor, net cash proceeds totaled to $3.8 million.  The Company used $950,000 of the net proceeds to repay “in full” (with concessions) the Promissory Note due to Main Power.
	The Company also issued a warrant to purchase 125,000 shares of the Company’s common stock to the placement agent.  This warrant has an exercise price of $1.54 per share (125% of the average closing price of the Company’s common stock during the five-day period prior to the April 22, 2013 closing date). The value of this warrant was estimated at $108,000, based on the Black-Scholes model with a stock price of $1.30, calculated exercise price of $1.54, expected life of three years, annualized volatility of 117.2% and a discount rate of 0.39%. The value of the warrant was recorded as stock issuance costs.
	The Series B Preferred Stock is convertible into 2.6 million shares of the Company’s common stock ($4.0 million divided by a conversion price of $1.51 per share).  The Series B Preferred Stock bears a cumulative annual dividend of 8.0%, payable in shares of the Company’s common stock at a conversion price of $1.51 per share (subject to customary anti-dilution rights, as described in the Series B Preferred Stock Certificates of Designations).  The Series B Preferred Stock does not have a liquidation preference and shall vote on an “as-converted” basis with the common stock.  The stock dividend will accrue from day to day and will be payable in shares of our common stock within thirty days after the end of each fiscal year end.  The stock dividend issuable will be recorded at the fair market value of our common stock at the end of each quarter in the equity section of the balance sheet.  The corresponding charge will be recorded below net income to arrive at net income available to common shareholders.  The Series B Preferred Stock automatically converts into the Company’s common stock: (i) upon the affirmative election of the holders of at least a majority of the then outstanding shares of the Series B Preferred Stock voting together as a single class on an as-if-converted to common stock basis; or (ii) if, at the date of exercise in whole or in part of the Warrant, the holder (or holders) of the Series B Preferred Stock own 50.1% of the issued and the Company’s then-outstanding common stock, giving effect to the issuance of shares of common stock in connection with the conversion of the Series B Preferred Stock and such exercise of the Warrant.
	The Warrant entitles, but does not obligate, Scotts Miracle-Gro to purchase a number of shares of common stock that, on a “fully diluted basis” (as defined in the Securities Purchase Agreement), constitute 80% of the Company’s outstanding capital stock (when added to all other shares owned by Scotts Miracle-Gro), as calculated as of the date or dates of exercise.  The Warrant can be exercised at any time and from time to time for a period of five years between April 22, 2016 and April 22, 2021 (the third and eighth anniversary of the closing date).  In addition, the Warrant can be exercised in any increment; there is no obligation to exercise the entire Warrant at one time.  The exercise price of the Warrant shall be equal to the quotient obtained by dividing:
		(a)	an amount equal to (i) 1.34 times the trailing twelve months “Net Sales” (which includes sales of the Company’s products by Scotts Miracle-Gro and its affiliates) minus (ii) “Debt Outstanding” net of cash (as such terms are defined in the Warrant),
	by
		(b)	the total shares of capital stock outstanding, including outstanding in-the-money options and warrants, but not the Warrant contemplated in this Private Offering.
	The Warrant expires on April 22, 2021, the eighth anniversary of the closing date.  The Warrant contains customary anti-dilution rights (for stock splits, stock dividends and sales of substantially all the Company’s assets).  Scotts Miracle-Gro also has the right to participate pro rata, based on Scotts Miracle-Gro’s percentage equity ownership in the Company (assuming the exercise of Scotts Miracle-Gro’s Warrant, but not the exercise of any options outstanding under the Company’s equity compensation plans) in future issuances of the Company’s equity securities.  Upon exercise of the Warrant and demand by Scotts Miracle-Gro, the Company must use its best efforts to file a Registration Statement on Form S-3, or, if the Company is not eligible for Form S-3, on Form S-1 (collectively, the “Registration Statement”), covering the shares of the Company’s common stock covered by the Preferred Stock and the Warrant, within 120 calendar days after receipt of Scotts Miracle-Gro’s demand for registration and shall use its best efforts to cause the Registration Statement to become effective as soon as possible thereafter.
	The private offering and sale of the Series B Preferred Stock and Warrant was conducted in reliance upon exemptions from registration requirements under the Securities Act, including, without limitation, those under Regulation D promulgated under the Securities Act.  Scotts Miracle-Gro is an “accredited investor,” as defined in Rule 501 of Regulation D under the Securities Act.  Because the Series B Preferred Stock and the Warrant have not been registered under the Securities Act, they may not be reoffered or resold in the United States absent registration or an applicable exemption from registration.
	The foregoing description of the Securities Purchase Agreement, the Certificates of Designations for the Series B Preferred Stock, the Warrant, and the resulting transaction is only a summary, does not purport to be complete, and is qualified in its entirety by reference to the full text of the applicable documents, each of which was included as an exhibit to the Company’s Current Report on Form 8-K, as filed with the SEC on April 23, 2013. The Warrant on the Series B Convertible Preferred Stock was accounted for as a liability at its estimated fair value of $595,000 as of December 31, 2013. The derivative warrant liability will be re-measured to fair value, on a recurring basis, at the end of each reporting period it is exercised or expires. The Company calculated the fair value of the Warrant during the quarter ended December 31, 2013 using a multiple based valuation model.
	In conjunction with the private offering of Series B Preferred Stock and the Warrant above, the Company used $950,000 of the net proceeds to repay “in full” (with concessions) the Main Power Promissory Note.  Main Power also released the Company’s pledged collateral and the parties agreed to terminate the Letter Agreement and Promissory Note effective as of April 22, 2013, as further described in Note 3.  The Company did not incur any early termination penalties. As of April 23, 2013, there was $237,000 in consignment inventory held by Main Power that was fully reserved for during the three-month period ended June 30, 2013.
	In conjunction with the private offering described above, the Company and Scotts Miracle-Gro also agreed to enter an Intellectual Property Sale Agreement, a Technology License Agreement, a Brand License Agreement, and a Supply Chain Services Agreement.  The Intellectual Property Sale Agreement and the Technology License constitute an agreement of sales of future revenues.
	For more details, please refer to Note 8 “Subsequent Events” to the financial statements included in the Company’s Annual Report on Form 10-K, as filed with the SEC on July 1, 2013.

5_Equity_Compensation_Plans

5. Equity Compensation Plans	9 Months Ended
	Dec. 31, 2013
Share-based Arrangements with Employees and Nonemployees [Abstract]	'
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]	'
	5.    Equity Compensation Plans
	On October 17, 2012, the Company implemented a 1-for-100 reverse stock split of its common stock that had previously been approved by stockholders.  As a result of the reverse stock split, every 100 shares of AeroGrow’s pre-reverse common stock were converted automatically into one share of common stock. All references below to shares of common stock, common stock warrants, or common stock options have been adjusted to reflect the reverse stock split.
	For the three months ended December 31, 2013, the Company granted 180,000 options to purchase the Company’s common stock under the Company’s 2005 Equity Compensation Plan (the “2005 Plan”).  For the nine months ended December 31, 2013, the Company granted options to purchase 331,000 options to purchase the Company’s common stock under the 2005 Plan.  For the three and nine months ended December 31, 2012, the Company did not grant any options to purchase the Company’s common stock under the 2005 Plan.
	During the three months ended December 31, 2013, options to purchase 75,000 shares of common stock were cancelled or expired, and 2,000 shares of common stock were issued upon exercise of outstanding stock options under the 2005 Plan.  During the three months ended December 31, 2012, options to purchase 1,000 shares of common stock were cancelled or expired, and no shares of common stock were issued upon exercise of outstanding stock options under the 2005 Plan.
	During the nine months ended December 31, 2013, options to purchase 109,000 shares of common stock were cancelled or expired, and 2,000 shares of common stock were issued upon exercise of outstanding stock options under the 2005 Plan.  During the nine months ended December 31, 2012, options to purchase 1,000 shares of common stock were cancelled or expired, and no shares of common stock were issued upon exercise of outstanding stock options under the 2005 Plan.
	As of December 31, 2013, the Company had granted options to purchase 274,000 shares of the Company’s common stock that are unvested and that will result in $316,000 of compensation expense in future periods if fully vested.
	Information regarding all stock options outstanding under the 2005 Plan as of December 31, 2013 is as follows:
			OPTIONS OUTSTANDING								OPTIONS EXERCISABLE
					Weighted-								Weighted-
					average		Weighted-		Aggregate				average		Weighted-		Aggregate
					Remaining		average		Intrinsic				Remaining		average		Intrinsic
	Exercise		Options		Contractual		Exercise		Value		Options		Contractual		Exercise		Value
	price		(in thousands)		Life (years)		Price		(in thousands)		(in thousands)		Life (years)		Price		(in thousands)
	$	1.01		162		4.1	$	1.01				74		4.1	$	1.01
	$	1.1		100		4.25	$	1.1				75		4.25	$	1.1
	$	1.21		50		4.25	$	1.21				38		4.25	$	1.21
	$	2.2		164		4.77	$	2.2				23		4.77	$	1.21
	$	2.42		10		4.77	$	2.42				2		4.77	$	1.21
	$	7		1		1.33	$	7				1		1.33	$	7
	$	8		5		1.92	$	8				5		1.92	$	8
	$	12		1		0.6	$	12				1		0.6	$	12
	$	13		1		0.61	$	13				1		0.61	$	13
	$	14		0		1.47	$	14				0		1.47	$	14
	$	18		5		0.17	$	18				5		0.17	$	18
	$	20		0		1	$	20				0		1	$	20
				499		4.3	$	1.77	$	497		225		4.07	$	1.88	$	271
	The aggregate intrinsic value in the preceding table represents the difference between the Company’s closing stock price and the exercise price of each in-the-money option on the last trading day of the period presented, which was December 31, 2013.

6_Income_Taxes

6. Income Taxes	9 Months Ended
	Dec. 31, 2013
Income Tax Disclosure [Abstract]	'
Income Tax Disclosure [Text Block]	'
	6.    Income Taxes
	The Company follows the guidance in ASC 740, Accounting for Uncertainty in Income Taxes (“ASC 740”) which clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements.  This interpretation defines the minimum recognition threshold a tax position is required to meet before being recognized in the financial statements.
	Deferred income taxes are recognized for the tax consequences in future years of differences between the tax basis of assets and liabilities and their financial reporting amounts at the end of each period, based on enacted laws and statutory rates applicable to the periods in which the differences are expected to affect taxable income.  Any liability for actual taxes to taxing authorities is recorded as income tax liability. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.  A valuation allowance is established against such assets where management is unable to conclude more likely than not that such asset will be realized. As of December 31, 2013 and March 31, 2013, the Company recognized a valuation allowance equal to 100% of the net deferred tax asset balance and the Company has no unrecognized tax benefits related to uncertain tax positions.

7_Related_Party_Transactions

7. Related Party Transactions	9 Months Ended
	Dec. 31, 2013
Related Party Transactions [Abstract]	'
Related Party Transactions Disclosure [Text Block]	'
	7.    Related Party Transactions
	See Note 3. Notes Payable, Long Term Debt and Current Portion – Long Term Debt for disclosure of related party transactions.

8_Stockholders_Equity

8. Stockholders' Equity	9 Months Ended
	Dec. 31, 2013
Stockholders' Equity Note [Abstract]	'
Stockholders' Equity Note Disclosure [Text Block]	'
	8.    Stockholders’ Equity
	On October 17, 2012, a 1-for-100 reverse stock split of AeroGrow’s common stock became effective.  As a result of the reverse stock split, every 100 shares of AeroGrow’s pre-reverse common stock were converted automatically into one share of common stock.  All references below to shares of common stock, common stock warrants, or common stock options have been adjusted to reflect the reverse stock split.
	A summary of the Company’s common stock warrant activity for the period from April 1, 2013 through December 31, 2013 is presented below:
			Warrants				Weighted				Aggregate
			Outstanding				Average				Intrinsic Value
			(in thousands)				Exercise Price
	Outstanding, April 1, 2013			528			$	22.41			$	0
	Granted			175				1.7
	Exercised			-				-
	Expired			0				0.98
	Outstanding, December 31, 2013			703			$	17.22			$	0
	As of December 31, 2013, the Company had the following outstanding warrants to purchase its common stock:
					Weighted Average
	Warrants Outstanding				Exercise Price				Remaining Life (years)
	(in thousands)
		125			$	1.54				4.31
		50			$	2.10				4.77
		394			$	7.00				3.28
		122			$	20.00				1.37
		1			$	25.00				0.77
		3			$	100.00				0.13
		7			$	800.00				0.68
		1			$	825.00				0.68
		703			$	17.22				3.19
	As discussed further in Note 4, the Company also issued a warrant that entitles, but not obligate Scotts Miracle-Gro to purchase a number of shares of common stock that, on a fully diluted basis, constitute 80% of the Company’s outstanding capital stock.

9_Subsequent_Events

9. Subsequent Events	9 Months Ended
	Dec. 31, 2013
Subsequent Events [Abstract]	'
Subsequent Events [Text Block]	'
	9.    Subsequent Events
	None

Accounting_Policies_by_Policy_

Accounting Policies, by Policy (Policies)	9 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Use of Estimates, Policy [Policy Text Block]	'
	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.  It is reasonably possible that a change in the Company’s estimates will occur in the near term.
Earnings Per Share, Policy [Policy Text Block]	'
	Net Income (Loss) per Share of Common Stock
	The Company computes net income (loss) per share of common stock in accordance with Accounting Standards Codification (“ASC”) 260.  ASC 260 requires companies with complex capital structures to present basic and diluted earnings per share (“EPS”).  Basic EPS is measured as the income or loss available to common stockholders divided by the weighted average shares of common stock outstanding for the period. Diluted EPS is similar to basic EPS, but presents the dilutive effect on a per share basis of potential common stock (e.g., convertible securities, options, and warrants) as if they had been converted at the beginning of the periods presented. Potential shares of common stock that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS.
	The following table presents the computation of basic and diluted net income per share for the three months ended December 31, 2013 (in thousands, except per share amounts):
		31-Dec-13
	Net income available to common shareholders	$	76
	Basic:
	Weighted-average shares outstanding		5,906
	Basic net income per share	$	0.01
	Diluted:
	Weighted-average shares outstanding		5,906
	Add: Dilutive potential shares-Stock options		86
	Weighted-average shares used in computing diluted net income per share		5,992
	Diluted net income per share	$	0.01
	Employee stock options to purchase approximately 13,000 shares were outstanding and approximately 528,000 warrants to purchase common stock were outstanding but were not included in the computation of diluted net income per share because the effect of including such shares would have been antidilutive in the periods presented.
Reclassification, Policy [Policy Text Block]	'
	Reclassifications
	Certain prior year amounts have been reclassified to conform to current year presentation.
Concentration Risk, Credit Risk, Policy [Policy Text Block]	'
	Concentrations of Risk
	ASC 825-10-50-20 requires disclosure of significant concentrations of credit risk regardless of the degree of such risk.  Financial instruments with significant credit risk include cash deposits.  The amount on deposit with one financial institution exceeded the $250,000 federally insured limit as of December 31, 2013.  However, management believes that the financial institution is financially sound and the risk of loss is minimal.
	Customers:
	For the three months ended December 31, 2013, two customers, Amazon.com and Costco, represented 39.2% and 10.7% of the Company’s net revenue, respectively. For the three months ended December 31, 2012, two customers, Amazon.com and Canadian Tire Corporation, represented 19.3% and 12.8% of the Company’s net revenue, respectively. For the nine months ended December 31, 2013, two customers, Amazon.com and Costco, represented 33.6% and 7.9% of the Company’s net revenue, respectively. For the nine months ended December 31, 2012, two customers, Amazon.com and Canadian Tire Corporation, represented 10.4% and 7.9% of the Company’s net revenue, respectively.
	Suppliers:
	For the three months ended December 31, 2013, the Company purchased inventories and other inventory-related items from three suppliers totaling $839,000, $707,000, and $205,000, representing 29.3%, 24.7%, and 7.2% of cost of revenue, respectively. For the three months ended December 31, 2012, the Company purchased inventories and other inventory-related items from two suppliers totaling $263,000 and $254,000, representing 15.8% and 15.3% of cost of revenue, respectively. For the nine months ended December 31, 2013, the Company purchased inventories and other inventory-related items from three suppliers totaling $1.4 million, $992,000, and $270,000 representing 34.4%, 24.9%, and 6.8%, of cost of revenue, respectively. For the nine months ended December 31, 2012, the Company purchased inventories and other inventory-related items from four suppliers totaling $587,000, $433,000, $392,000, and $334,000 representing 20.2%, 14.9%, 13.5%, and 11.5% of cost of revenue, respectively.
	The Company’s primary contract manufacturers are located in China.  As a result, the Company may be subject to political, currency, regulatory and weather/natural disaster risks.  Although the Company believes alternate sources of manufacturing could be obtained, these risks could have an adverse impact on operations.
	Accounts Receivable:
	As of December 31, 2013, the Company had two customers, Amazon.com and Costco, that represented 62.3% and 23.6% of the Company’s outstanding accounts receivable, respectively.  As of March 31, 2013, the Company one customer, Amazon.com  who represented 61.2% of outstanding accounts receivable.  The Company believes that all receivables from these customers are collectible.
Fair Value of Financial Instruments, Policy [Policy Text Block]	'
	Fair Value of Financial Instruments
	The Company follows the guidance in ASC 820, Fair Value Measurements and Disclosures (“ASC 820”), as it relates to the fair value of its financial assets and liabilities. ASC 820 provides for a standard definition of fair value to be used in new and existing pronouncements. This guidance requires disclosure of fair value information about certain financial instruments (insurance contracts, real estate, goodwill and taxes are excluded) for which it is practicable to estimate such values, whether or not these instruments are included in the balance sheet at fair value. The fair values presented for certain financial instruments are estimates which, in many cases, may differ significantly from the amounts that could be realized upon immediate liquidation.
	Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability, i.e., exit price, in an orderly transaction between market participants.  ASC 820 also provides a hierarchy for determining fair value, which emphasizes the use of observable market data whenever available. The three broad levels defined by the hierarchy are as follows, with the highest priority given to Level 1 as these are the most reliable, and the lowest priority given to Level 3.
	Level 1 – Quoted prices in active markets for identical assets.
	Level 2 – Quoted prices for similar assets in active markets, quoted prices for identical or similar assets in markets that are not active, or other inputs that are observable or can be corroborated by observable market data, including model-derived valuations.
	Level 3 – Unobservable inputs that are supported by little or no market activity.
	The carrying value of financial instruments including receivables and accounts payable, approximates their fair value at December 31, 2013 and March 31, 2013 due to the relatively short-term nature of these instruments. As of December 31, 2013 and March 31, 2013, the fair value of the Company's debt, notes payable, and sale of intellectual property liability using Level 3 inputs was estimated using the discounted cash flow method, which is based on the future expected cash flows, discounted to their present values, using a discount rate of 15%.
	In conjunction with a Securities Purchase Agreement and strategic alliance with a wholly owned subsidiary of The Scotts Miracle-Gro Company (collectively with the subsidiary, “Scotts Miracle-Gro”) on April 22, 2013, the Company issued a warrant that entitles, but does not obligate, Scotts Miracle-Gro to purchase a number of shares of common stock that, on a fully diluted basis, constitute 80% of the Company’s outstanding capital stock. This warrant was accounted for as a liability at its estimated fair value. The Company calculated the fair value of the warrant during the quarter ended December 31, 2013 using a multiple based valuation model.  As of December 31, 2013, the Company measured the warrant at fair value and will continue to do so on a quarterly basis.  As of March 31, 2013, the Company did not have any financial assets or liabilities that were measured at fair value on a recurring basis subsequent to initial recognition.
Receivables, Policy [Policy Text Block]	'
	Accounts Receivable and Allowance for Doubtful Accounts
	The Company sells its products to retailers and consumers. Consumer transactions are primarily paid by credit card.  Retailer sales terms vary by customer, but generally range from net 30 days to net 60 days.  Accounts receivable are reported at net realizable value and net of the allowance for doubtful accounts. The Company uses the allowance method to account for uncollectible accounts receivable. The Company's allowance estimate is based on a review of the current status of trade accounts receivable, which resulted in an allowance of $13,000 and $1,000 at December 31, 2013 and March 31, 2013, respectively.
	Other Receivables
	In conjunction with the Company’s processing of credit card transactions for its direct-to-consumer sales activities and as security with respect to the Company’s performance for credit card refunds and charge backs, the Company is required to maintain a cash reserve with Litle and Company, the Company’s credit card processor. This reserve is equal to 5% of the credit card sales processed during the previous six months. As of December 31, 2013 and March 31, 2013, the balance in this reserve account was $131,000 and $169,000, respectively.
Advertising Costs, Policy [Policy Text Block]	'
	Advertising and Production Costs
	The Company expenses all production costs related to advertising, including print, television, and radio advertisements when the advertisement has been broadcast or otherwise distributed.  The Company records media costs related to its direct-to-consumer advertisements, inclusive of postage and printing costs incurred in conjunction with mailings of direct-response catalogues, and related direct-response advertising costs, in accordance with ASC 340-20-Reporting on Advertising Costs.  As prescribed by ASC 340-20-25, direct-to-consumer advertising costs incurred are reported as assets and are amortized over the estimated period of the benefits, based on the proportion of current period revenue from the advertisement to probable future revenue.
	As the Company has re-entered the retail distribution channel, the Company has expanded its advertising to online gateway and portal advertising, as well as placement in third party catalogues.
	Advertising expense for the three and nine months ended December 31, 2013 and December 31, 2012, were as follows:
		Three Months Ended				Nine Months Ended
		December 31,				December 31,
		(in thousands)				(in thousands)
		2013		2012		2013		2012
	Direct-to-consumer	$	391	$	534	$	506	$	825
	Retail		390		1		393		1
	Total advertising expense	$	781	$	535	$	899	$	826
	As of December 31, 2013 and March 31, 2013, the Company deferred $6,000 and $4,000, respectively, related to such media and advertising costs.
		December 31,		March 31,
		2013		2013
		(in thousands)		(in thousands)
	Deferred advertising and media	$	6	$	4
	Inventory
	Inventories are valued at the lower of cost, determined by the first-in, first-out method, or market.  Included in inventory costs where the Company is the manufacturer are raw materials, labor, and manufacturing overhead. The Company records the raw materials at delivered cost. Standard labor and manufacturing overhead costs are applied to the finished goods based on normal production capacity.  A majority of the Company’s products are manufactured overseas and are recorded at cost.
		December 31,		March 31,
		2013		2013
		(in thousands)		(in thousands)
	Finished goods	$	1,124	$	606
	Raw materials		474		623
		$	1,598	$	1,229
Inventory, Policy [Policy Text Block]	'
	Inventory
	Inventories are valued at the lower of cost, determined by the first-in, first-out method, or market.  Included in inventory costs where the Company is the manufacturer are raw materials, labor, and manufacturing overhead. The Company records the raw materials at delivered cost. Standard labor and manufacturing overhead costs are applied to the finished goods based on normal production capacity.  A majority of the Company’s products are manufactured overseas and are recorded at cost.
		December 31,		March 31,
		2013		2013
		(in thousands)		(in thousands)
	Finished goods	$	1,124	$	606
	Raw materials		474		623
		$	1,598	$	1,229
	The Company determines an inventory obsolescence reserve based on management’s historical experience and establishes reserves against inventory according to the age of the product. As of December 31, 2013 and March 31, 2013, the Company had reserved $332,000 for inventory obsolescence.
Revenue Recognition, Policy [Policy Text Block]	'
	Revenue Recognition
	The Company recognizes revenue from product sales, net of estimated returns, when persuasive evidence of a sale exists: that is, a product is shipped under an agreement with a customer; risk of loss and title has passed to the customer; the fee is fixed or determinable; and collection of the resulting receivable is reasonably assured.
	The Company records estimated reductions to revenue for customer and distributor programs and incentive offerings, including promotions, rebates, and other volume-based incentives.  Certain incentive programs require the Company to estimate based on industry experience the number of customers who will actually redeem the incentive. As of December 31, 2013 and March 31, 2013, the Company had accrued $236,000 and $43,000, respectively, as its estimate for the foregoing deductions and allowances.
Standard Product Warranty, Policy [Policy Text Block]	'
	Warranty and Return Reserves
	The Company records warranty liabilities at the time of sale for the estimated costs that may be incurred under its basic warranty program. The specific warranty terms and conditions vary depending upon the product sold, but generally include technical support, repair parts, and labor for periods up to one year. Factors that affect the Company’s warranty liability include the number of installed units currently under warranty, historical and anticipated rates of warranty claims on those units, and cost per claim to satisfy the Company’s warranty obligation.  Based upon the foregoing, the Company has recorded a reserve for potential future warranty costs of $14,000 and $10,000 as of December 31, 2013 and March 31, 2013, respectively.
	The Company reserves for known and potential returns from customers and associated refunds or credits related to such returns based upon historical experience. In certain cases, retailer customers are provided a fixed allowance, usually in the 1% to 2% range, to cover returned goods and this allowance is deducted from payments made to us by such customers. As of December 31, 2013 and March 31, 2013, the Company has recorded a reserve for customer returns of $80,000 and $27,000, respectively.
New Accounting Pronouncements, Policy [Policy Text Block]	'
	Recently Issued Accounting Pronouncements
	In July 2013, the FASB issued ASU 2013-11, “Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists,” which among other things, requires an unrecognized tax benefit, or a portion of an unrecognized tax benefit, to be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward, except as denoted within the ASU. The amendments in this ASU are effective for fiscal years, and interim periods within those years, beginning after December 15, 2013. This new guidance will not have a material impact on our financial statements.

2_Liquidity_and_Basis_of_Prese1

2. Liquidity and Basis of Presentation (Tables)	9 Months Ended
	Dec. 31, 2013
Disclosure Text Block [Abstract]	'
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	'The following table presents the computation of basic and diluted net income per share for the three months ended December 31, 2013 (in thousands, except per share amounts):
		31-Dec-13
	Net income available to common shareholders	$	76
	Basic:
	Weighted-average shares outstanding		5,906
	Basic net income per share	$	0.01
	Diluted:
	Weighted-average shares outstanding		5,906
	Add: Dilutive potential shares-Stock options		86
	Weighted-average shares used in computing diluted net income per share		5,992
	Diluted net income per share	$	0.01
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	'
		31-Dec-13				31-Mar-13
		(in thousands)				(in thousands)
		Fair Value		Carry Value		Fair Value		Carry Value
	Liabilities
	Notes payable	$	-	$	-	$	610	$	641
	Sale of intellectual property liability		178		271		-		-
	Derivative warrant liability		595		595		-		-
	Long-term debt		109		112		1,726		2,068
	Total	$	882	$	978	$	2,336	$	2,709
Schedule of Other Operating Cost and Expense, by Component [Table Text Block]	'Advertising expense for the three and nine months ended December 31, 2013 and December 31, 2012, were as follows:
		Three Months Ended				Nine Months Ended
		December 31,				December 31,
		(in thousands)				(in thousands)
		2013		2012		2013		2012
	Direct-to-consumer	$	391	$	534	$	506	$	825
	Retail		390		1		393		1
	Total advertising expense	$	781	$	535	$	899	$	826
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]	'As of December 31, 2013 and March 31, 2013, the Company deferred $6,000 and $4,000, respectively, related to such media and advertising costs.
		December 31,		March 31,
		2013		2013
		(in thousands)		(in thousands)
	Deferred advertising and media	$	6	$	4
Schedule of Inventory, Current [Table Text Block]	'
		December 31,		March 31,
		2013		2013
		(in thousands)		(in thousands)
	Finished goods	$	1,124	$	606
	Raw materials		474		623
		$	1,598	$	1,229

3_Notes_Payable_Long_Term_Debt1

3. Notes Payable, Long Term Debt and Current Portion - Long Term Debt (Tables)	9 Months Ended
	Dec. 31, 2013
Debt Disclosure [Abstract]	'
Schedule of Debt [Table Text Block]	'As of December 31, 2013 and March 31, 2013, the outstanding balance of the Company’s note payable and debt, including accrued interest, is as follows:
		December 31,		March 31,
		2013		2013
		(in thousands)		(in thousands)
	Main Power promissory note	$	-	$	1,704
	First Western Trust term loan		99		323
	Notes Payable –credit card receipts-backed notes		-		640
	Pawnee promissory note		13		42
	Sale of intellectual property liability (see Note 4)		271		-
	Derivative warrant liability (see Note 4)		595		-
	Total debt		978		2,709
	Less notes payable and current portion – long term debt		978		1,540
	Long term debt	$	-	$	1,169

5_Equity_Compensation_Plans_Ta

5. Equity Compensation Plans (Tables)	9 Months Ended
	Dec. 31, 2013
Share-based Arrangements with Employees and Nonemployees [Abstract]	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block]	'Information regarding all stock options outstanding under the 2005 Plan as of December 31, 2013 is as follows:
			OPTIONS OUTSTANDING								OPTIONS EXERCISABLE
					Weighted-								Weighted-
					average		Weighted-		Aggregate				average		Weighted-		Aggregate
					Remaining		average		Intrinsic				Remaining		average		Intrinsic
	Exercise		Options		Contractual		Exercise		Value		Options		Contractual		Exercise		Value
	price		(in thousands)		Life (years)		Price		(in thousands)		(in thousands)		Life (years)		Price		(in thousands)
	$	1.01		162		4.1	$	1.01				74		4.1	$	1.01
	$	1.1		100		4.25	$	1.1				75		4.25	$	1.1
	$	1.21		50		4.25	$	1.21				38		4.25	$	1.21
	$	2.2		164		4.77	$	2.2				23		4.77	$	1.21
	$	2.42		10		4.77	$	2.42				2		4.77	$	1.21
	$	7		1		1.33	$	7				1		1.33	$	7
	$	8		5		1.92	$	8				5		1.92	$	8
	$	12		1		0.6	$	12				1		0.6	$	12
	$	13		1		0.61	$	13				1		0.61	$	13
	$	14		0		1.47	$	14				0		1.47	$	14
	$	18		5		0.17	$	18				5		0.17	$	18
	$	20		0		1	$	20				0		1	$	20
				499		4.3	$	1.77	$	497		225		4.07	$	1.88	$	271

8_Stockholders_Equity_Tables

8. Stockholders' Equity (Tables)	9 Months Ended
	Dec. 31, 2013
Stockholders' Equity Note [Abstract]	'
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	'A summary of the Company’s common stock warrant activity for the period from April 1, 2013 through December 31, 2013 is presented below:
			Warrants				Weighted				Aggregate
			Outstanding				Average				Intrinsic Value
			(in thousands)				Exercise Price
	Outstanding, April 1, 2013			528			$	22.41			$	0
	Granted			175				1.7
	Exercised			-				-
	Expired			0				0.98
	Outstanding, December 31, 2013			703			$	17.22			$	0
Schedule of Stockholders Equity [Table Text Block]	'As of December 31, 2013, the Company had the following outstanding warrants to purchase its common stock:
					Weighted Average
	Warrants Outstanding				Exercise Price				Remaining Life (years)
	(in thousands)
		125			$	1.54				4.31
		50			$	2.10				4.77
		394			$	7.00				3.28
		122			$	20.00				1.37
		1			$	25.00				0.77
		3			$	100.00				0.13
		7			$	800.00				0.68
		1			$	825.00				0.68
		703			$	17.22				3.19

2_Liquidity_and_Basis_of_Prese2

2. Liquidity and Basis of Presentation (Details) (USD $)

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

12 Months Ended

Share data in Millions, unless otherwise specified

Dec. 31, 2013

Mar. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Mar. 31, 2013

Dec. 31, 2013

Mar. 31, 2013

Major Customer 1 [Member]

Major Customer 1 [Member]

Major Customer 1 [Member]

Major Customer 1 [Member]

Major Customer 1 [Member]

Major Customer 2 [Member]

Major Customer 2 [Member]

Major Customer 2 [Member]

Major Customer 2 [Member]

Major Customer 2 [Member]

Equity Option [Member]

Warrant [Member]

Major Supplier 1 [Member]

Major Supplier 1 [Member]

Major Supplier 1 [Member]

Major Supplier 1 [Member]

Major Supplier 2 [Member]

Major Supplier 2 [Member]

Major Supplier 2 [Member]

Major Supplier 2 [Member]

Major Supplier 3 [Member]

Major Supplier 3 [Member]

Major Supplier 3 [Member]

Major Supplier 4 [Member]

Customer Concentration Risk [Member]

Customer Concentration Risk [Member]

Customer Concentration Risk [Member]

Customer Concentration Risk [Member]

Supplier Concentration Risk [Member]

Supplier Concentration Risk [Member]

Supplier Concentration Risk [Member]

Supplier Concentration Risk [Member]

Credit Concentration Risk [Member]

Credit Concentration Risk [Member]

Allowance for Sales Returns [Member]

Allowance for Sales Returns [Member]

Customer Concentration Risk [Member]

Customer Concentration Risk [Member]

Customer Concentration Risk [Member]

Customer Concentration Risk [Member]

Credit Concentration Risk [Member]

Customer Concentration Risk [Member]

Customer Concentration Risk [Member]

Customer Concentration Risk [Member]

Customer Concentration Risk [Member]

Credit Concentration Risk [Member]

Supplier Concentration Risk [Member]

Supplier Concentration Risk [Member]

Supplier Concentration Risk [Member]

Supplier Concentration Risk [Member]

Supplier Concentration Risk [Member]

Supplier Concentration Risk [Member]

Supplier Concentration Risk [Member]

Supplier Concentration Risk [Member]

Supplier Concentration Risk [Member]

Supplier Concentration Risk [Member]

Supplier Concentration Risk [Member]

Supplier Concentration Risk [Member]

Sales [Member]

Sales [Member]

Sales [Member]

Sales [Member]

Cost of Goods, Total [Member]

Cost of Goods, Total [Member]

Cost of Goods, Total [Member]

Cost of Goods, Total [Member]

Accounts Receivable [Member]

Accounts Receivable [Member]

Sales [Member]

Sales [Member]

Sales [Member]

Sales [Member]

Accounts Receivable [Member]

Sales [Member]

Sales [Member]

Sales [Member]

Sales [Member]

Accounts Receivable [Member]

Cost of Goods, Total [Member]

Cost of Goods, Total [Member]

Cost of Goods, Total [Member]

Cost of Goods, Total [Member]

Cost of Goods, Total [Member]

Cost of Goods, Total [Member]

Cost of Goods, Total [Member]

Cost of Goods, Total [Member]

Cost of Goods, Total [Member]

Cost of Goods, Total [Member]

Cost of Goods, Total [Member]

Cost of Goods, Total [Member]

2. Liquidity and Basis of Presentation (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)

'

'

'

'

'

'

'

'

'

'

'

'

13,000

528,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of financial institutions with deposits in excess of federally insured limit

1

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Cash, FDIC Insured Amount

$250,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Concentration Risk, Customer

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'two customers

'two customers

'two customers

'two customers

'

'

'

'

'two customers

'one customer

'

'

Concentration Risk, Percentage

'

'

39.20%

19.30%

33.60%

10.40%

62.30%

10.70%

12.80%

7.90%

7.90%

23.60%

'

'

29.30%

15.80%

34.40%

20.20%

24.70%

15.30%

24.90%

14.90%

7.20%

6.80%

13.50%

11.50%

'

'

'

'

'

'

'

'

'

61.20%

'

'

Concentration Risk, Supplier

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'three suppliers

'two suppliers

'three suppliers

'four suppliers

'

'

'

'

Cost of Goods Sold

'

'

'

'

'

'

'

'

'

'

'

'

'

'

839,000

263,000

1,400,000

587,000

707,000

254,000

992,000

433,000

205,000

270,000

392,000

334,000

'

'

'

'

'

'

'

'

'

'

'

'

Fair Value Inputs, Discount Rate

15.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Security Purchase Agreement, Description

'a Securities Purchase Agreement and strategic alliance with a wholly owned subsidiary of The Scotts Miracle-Gro Company (collectively with the subsidiary, "Scotts Miracle-Gro") on April 22, 2013, the Company issued a warrant that entitles, but does not obligate, Scotts Miracle-Gro to purchase a number of shares of common stock that, on a fully diluted basis, constitute 80% of the Company's outstanding capital stock.

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Allowance for Doubtful Accounts Receivable, Current

13,000

1,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Other receivable, reserve percentage of credit card sales

5.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Deposits Assets, Current

131,000

169,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Deferred Advertising Costs

6,000

4,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Inventory Valuation Reserves

332,000

332,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Other Accrued Liabilities

236,000

43,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Provision for Future Warranty Costs

14,000

10,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Customer Refund Liability, Current

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$80,000

$27,000

2_Liquidity_and_Basis_of_Prese3

2. Liquidity and Basis of Presentation (Details) - Schedule of Earnings Per Share, Basic and Diluted (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Schedule of Earnings Per Share, Basic and Diluted [Abstract]	'	'	'	'
Net income available to common shareholders (in Dollars)	$76	($297)	($881)	($7,863)
Basic:	'	'	'	'
Weighted-average shares outstanding	5,906	5,905	5,905	5,826
Basic net income per share (in Dollars per share)	$0.01	($0.05)	($0.10)	($1.35)
Diluted:	'	'	'	'
Weighted-average shares outstanding	5,906	5,905	5,905	5,826
Add: Dilutive potential shares-Stock options	86	'	'	'
Weighted-average shares used in computing diluted net income per share	5,992	5,905	5,905	5,826
Diluted net income per share (in Dollars per share)	$0.01	($0.05)	($0.10)	($1.35)

2_Liquidity_and_Basis_of_Prese4

2. Liquidity and Basis of Presentation (Details) - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (USD $)	Dec. 31, 2013	Mar. 31, 2013
In Thousands, unless otherwise specified
Liabilities	'	'
Derivative warrant liability	$595	'
Long-term debt	978	2,709
Estimate of Fair Value Measurement [Member]	'	'
Liabilities	'	'
Notes payable	0	610
Sale of intellectual property liability	178	0
Derivative warrant liability	595	0
Long-term debt	109	1,726
Total	882	2,336
Reported Value Measurement [Member]	'	'
Liabilities	'	'
Notes payable	0	641
Sale of intellectual property liability	271	0
Derivative warrant liability	595	0
Long-term debt	112	2,068
Total	$978	$2,709

2_Liquidity_and_Basis_of_Prese5

2. Liquidity and Basis of Presentation (Details) - Schedule of Advertising Expense (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
2. Liquidity and Basis of Presentation (Details) - Schedule of Advertising Expense [Line Items]	'	'	'	'
Advertising Expense	$781	$535	$899	$826
Direct-to-Customer Advertising [Member]	'	'	'	'
2. Liquidity and Basis of Presentation (Details) - Schedule of Advertising Expense [Line Items]	'	'	'	'
Advertising Expense	391	534	506	825
Retail Advertising [Member]	'	'	'	'
2. Liquidity and Basis of Presentation (Details) - Schedule of Advertising Expense [Line Items]	'	'	'	'
Advertising Expense	$390	$1	$393	$1

2_Liquidity_and_Basis_of_Prese6

2. Liquidity and Basis of Presentation (Details) - Schedule of Deferred Advertising Costs (USD $)	Dec. 31, 2013	Mar. 31, 2013
In Thousands, unless otherwise specified
Schedule of Deferred Advertising Costs [Abstract]	'	'
Deferred advertising and media	$6	$4

2_Liquidity_and_Basis_of_Prese7

2. Liquidity and Basis of Presentation (Details) - Schedule of Inventory, Current (USD $)	Dec. 31, 2013	Mar. 31, 2013
In Thousands, unless otherwise specified
Schedule of Inventory, Current [Abstract]	'	'
Finished goods	$1,124	$606
Raw materials	474	623
	$1,598	$1,229

3_Notes_Payable_Long_Term_Debt2

3. Notes Payable, Long Term Debt and Current Portion - Long Term Debt (Details) (USD $)

9 Months Ended

12 Months Ended

9 Months Ended

9 Months Ended

12 Months Ended

9 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Mar. 31, 2013

Mar. 31, 2013

Mar. 31, 2013

Mar. 31, 2013

Mar. 31, 2013

Dec. 31, 2013

Mar. 31, 2013

Dec. 31, 2013

Mar. 31, 2013

Mar. 31, 2013

Mar. 31, 2013

Dec. 31, 2013

Mar. 31, 2013

Dec. 31, 2013

Investor [Member]

Company-Referred Investors [Member]

Directors and Officers [Member]

Issued to Placement Agent [Member]

Main Power Promissory Note [Member]

Main Power Promissory Note [Member]

First Western Trust Term Loan [Member]

First Western Trust Term Loan [Member]

2012 Credit Card Receipts [Member]

2011 Credit Card Receipts-Backed Notes [Member]

Pawnee Promissory Note [Member]

Pawnee Promissory Note [Member]

Scotts Miracle-Gro Company [Member]

2012 Credit Card Receipts [Member]

2012 Credit Card Receipts [Member]

2012 Credit Card Receipts [Member]

2012 Credit Card Receipts [Member]

3. Notes Payable, Long Term Debt and Current Portion - Long Term Debt (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Face Amount

'

'

'

'

'

'

'

$1,400,000

'

$1,000,000

'

$1,300,000

'

$116,000

'

'

Debt Instrument, Maturity Date, Description

'

'

'

'

'

'

'

'extend the payment schedule, maturity date and

'

'

'

'

'

'

'

'

Repayments of Long-term Debt

1,243,000

251,000

'

'

'

'

'

950,000

'

'

'

'

'

'

'

'

Inventory Valuation Reserves

332,000

'

332,000

'

'

'

'

237,000

'

'

'

'

'

'

'

'

Gains (Losses) on Extinguishment of Debt

489,000

0

'

'

'

'

'

489,000

'

'

'

'

'

'

'

'

Debt Instrument, Collateral

'

'

'

'

'

'

'

'

'

'secured by a lien on our assets

'

'backed by a portion of the Company's prospective credit card receipts, (the "2012 Credit Card Notes") and 128,573 shares of common stock (collectively, the "2012 Credit Card Offering")

'

'

'

'

Debt Instrument, Interest Rate, Stated Percentage

'

'

'

'

'

'

'

'

'

7.25%

'

15.00%

'

'

'

'

Debt Instrument, Payment Terms

'

'

'

'

'

'

'

'

'

'equal monthly payments of principal/interest over the four-year term of the FWTB Term

'

'

'

'

'

'

Debt Instrument, Maturity Date

'

'

'

'

'

'

'

'

'

21-May-14

'

'

'

'

'

'

Long-term Debt

978,000

'

2,709,000

'

'

'

'

0

1,704,000

99,000

323,000

'

'

13,000

42,000

'

Debt, consideration

'

'

'

'

'

'

'

'

'

'

'

'comprised $1.3 million in cash

'

'

'

'

Debt Related Commitment Fees and Debt Issuance Costs

'

'

'

'

'

'

'

'

'

'

'

46,000

'

'

'

'

Debt, sales commission percentage

'

'

'

5.00%

3.00%

0.00%

'

'

'

'

'

'

'

'

'

'

Proceeds from Debt, Net of Issuance Costs

'

'

'

'

'

'

'

'

'

'

'

1,200,000

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period (in Shares)

'

'

'

'

'

'

12,858

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Terms of Award

'

'

'

'

'

'

'one share of common stock for every 10 shares issued to investors

'

'

'

'

'

'

'

'

'

Repayments of Debt (in Dollars)

'

'

'

'

'

'

'

950,000

'

'

'

'

198,000

'

'

'

Debt Instrument, Interest Rate Terms

'

'

'

'

'

'

'

'

'

'

'

'

'

'carries an interest rate of 6% per annum for the first twelve months, and 8% per annum thereafter

'

'

Derivative Liability, Current

595,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

595,000

Debt, Current

$271,000

'

$0

'

'

'

'

'

'

'

'

'

'

'

'

$271,000

3_Notes_Payable_Long_Term_Debt3

3. Notes Payable, Long Term Debt and Current Portion - Long Term Debt (Details) - Schedule of Debt (USD $)	Dec. 31, 2013	Mar. 31, 2013
In Thousands, unless otherwise specified
3. Notes Payable, Long Term Debt and Current Portion - Long Term Debt (Details) - Schedule of Debt [Line Items]	'	'
Long-Term Debt	$978	$2,709
Less notes payable and current portion – long term debt	978	1,540
Long term debt	0	1,169
Scotts Miracle-Gro Company [Member] | Sale of Intellectual Property Liability [Member]	'	'
3. Notes Payable, Long Term Debt and Current Portion - Long Term Debt (Details) - Schedule of Debt [Line Items]	'	'
Long-Term Debt	271	0
Scotts Miracle-Gro Company [Member] | Derivative Warrant Liability [Member]	'	'
3. Notes Payable, Long Term Debt and Current Portion - Long Term Debt (Details) - Schedule of Debt [Line Items]	'	'
Long-Term Debt	595	0
Main Power Promissory Note [Member]	'	'
3. Notes Payable, Long Term Debt and Current Portion - Long Term Debt (Details) - Schedule of Debt [Line Items]	'	'
Long-Term Debt	0	1,704
First Western Trust Term Loan [Member]	'	'
3. Notes Payable, Long Term Debt and Current Portion - Long Term Debt (Details) - Schedule of Debt [Line Items]	'	'
Long-Term Debt	99	323
Notes Payable - Credit Card Receipts Backed Notes [Member]	'	'
3. Notes Payable, Long Term Debt and Current Portion - Long Term Debt (Details) - Schedule of Debt [Line Items]	'	'
Long-Term Debt	0	640
Pawnee Promissory Note [Member]	'	'
3. Notes Payable, Long Term Debt and Current Portion - Long Term Debt (Details) - Schedule of Debt [Line Items]	'	'
Long-Term Debt	$13	$42

4_Scotts_MiracleGro_Transactio1

4. Scotts Miracle-Gro Transactions - Convertible Preferred Stock, Warrants and Other Transactions (Details) (USD $)	9 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Mar. 31, 2013
4. Scotts Miracle-Gro Transactions - Convertible Preferred Stock, Warrants and Other Transactions (Details) [Line Items]	'	'	'
Preferred Stock, Par or Stated Value Per Share (in Dollars per share)	$0.00	'	$0.00
Fair Value Adjustment of Warrants (in Dollars)	$108,000	$0	'
Fair Value Inputs, Discount Rate	15.00%	'	'
Warrants, Description of Warrants	'issued a warrant that entitles, but not obligate Scotts Miracle-Gro to purchase a number of shares of common stock that, on a fully diluted basis, constitute 80% of the Company's outstanding capital stock.	'	'
Scotts Miracle-Gro Company [Member] | Series B Preferred Stock [Member]	'	'	'
4. Scotts Miracle-Gro Transactions - Convertible Preferred Stock, Warrants and Other Transactions (Details) [Line Items]	'	'	'
Stock Issued During Period, Shares, New Issues (in Shares)	2,600,000	'	'
Preferred Stock, Par or Stated Value Per Share (in Dollars per share)	$0.00	'	'
Stock Issued During Period, Value, New Issues (in Dollars)	4,000,000	'	'
Proceeds from Issuance of Convertible Preferred Stock (in Dollars)	3,800,000	'	'
Convertible Preferred Stock, Shares Issued upon Conversion (in Shares)	2,600,000	'	'
Preferred Stock, Conversion Basis	'$4.0 million divided by a conversion price of $1.51 per share	'	'
Preferred Stock, Dividend Rate, Percentage	8.00%	'	'
Preferred Stock, Dividend Payment Terms	'The stock dividend will accrue from day to day and will be payable in shares of our common stock within thirty days after the end of each fiscal year end	'	'
Convertible Preferred Stock, Terms of Conversion	'(i) upon the affirmative election of the holders of at least a majority of the then outstanding shares of the Series B Preferred Stock voting together as a single class on an as-if-converted to common stock basis; or (ii) if, at the date of exercise in whole or in part of the Warrant, the holder (or holders) of the Series B Preferred Stock own 50.1% of the issued and the Company's then-outstanding common stock, giving effect to the issuance of shares of common stock in connection with the conversion of the Series B Preferred Stock and such exercise of the Warrant	'	'
Warrants, Description of Warrants	'The Warrant entitles, but does not obligate, Scotts Miracle-Gro to purchase a number of shares of common stock that, on a "fully diluted basis" (as defined in the Securities Purchase Agreement), constitute 80% of the Company's outstanding capital stock (when added to all other shares owned by Scotts Miracle-Gro), as calculated as of the date or dates of exercise.The Warrant can be exercised at any time and from time to time for a period of five years between April 22, 2016 and April 22, 2021 (the third and eighth anniversary of the closing date).In addition, the Warrant can be exercised in any increment; there is no obligation to exercise the entire Warrant at one time.The exercise price of the Warrant shall be equal to the quotient obtained by dividing:(a) an amount equal to (i) 1.34 times the trailing twelve months "Net Sales" (which includes sales of the Company's products by Scotts Miracle-Gro and its affiliates) minus (ii) "Debt Outstanding" net of cash (as such terms are defined in the Warrant),by(b) the total shares of capital stock outstanding, including outstanding in-the-money options and warrants, but not the Warrant contemplated in this Private Offering.	'	'
Derivative Liability (in Dollars)	595,000	'	'
Scotts Miracle-Gro Company [Member] | Placement Agent for Securities Purchase Agreement [Member]	'	'	'
4. Scotts Miracle-Gro Transactions - Convertible Preferred Stock, Warrants and Other Transactions (Details) [Line Items]	'	'	'
Class of Warrant or Rights, Granted (in Shares)	125,000	'	'
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per Item)	1.54	'	'
Class of Warrant or Rights, Exercise Price, Description	'125% of the average closing price of the Company's common stock during the five-day period prior to the April 22, 2013 closing date	'	'
Fair Value Adjustment of Warrants (in Dollars)	108,000	'	'
Share Price (in Dollars per share)	$1.30	'	'
Fair Value Assumptions, Expected Term	'3 years	'	'
Fair Value Assumptions, Expected Volatility Rate	117.20%	'	'
Fair Value Inputs, Discount Rate	0.39%	'	'
Main Power Promissory Note [Member]	'	'	'
4. Scotts Miracle-Gro Transactions - Convertible Preferred Stock, Warrants and Other Transactions (Details) [Line Items]	'	'	'
Repayments of Debt (in Dollars)	$950,000	'	'

5_Equity_Compensation_Plans_De

5. Equity Compensation Plans (Details) (USD $)	12 Months Ended	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2013	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
		Equity Compensation Plan (2005 Plan) [Member]	Equity Compensation Plan (2005 Plan) [Member]	Equity Compensation Plan (2005 Plan) [Member]	Equity Compensation Plan (2005 Plan) [Member]
5. Equity Compensation Plans (Details) [Line Items]	'	'	'	'	'
Stockholders' Equity, Reverse Stock Split	'1-for-100	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	'	180	'	331	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period	'	75	1	109	1
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period	'	2	0	2	0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares	'	274	'	274	'
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized (in Dollars)	'	$316	'	$316	'

5_Equity_Compensation_Plans_De1

5. Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable (USD $)	9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2013
5. Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]	'
OPTIONS OUTSTANDING - Options (in Shares)	499
OPTIONS OUTSTANDING - Weighted-Average Remaining Contractual Life (Years)	'4 years 109 days
OPTIONS OUTSTANDING - Weighted-Average Exercise Price	$1.77
OPTIONS OUTSTANDING - Aggregate Intrinsic Value (in Dollars)	$497
OPTIONS EXERCISABLE - Options (in Shares)	225
OPTIONS EXERCISABLE - Weighted-Average Remaining Contractual Life (Years)	'4 years 25 days
OPTIONS EXERCISABLE - Weighted-Average Exercise Price	$1.88
OPTIONS EXERCISABLE - Aggregate Intrinsic Value (in Dollars)	$271
Options Exercise Price $1.01 [Member]	'
5. Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]	'
Exercise Price Range	$1.01
OPTIONS OUTSTANDING - Options (in Shares)	162
OPTIONS OUTSTANDING - Weighted-Average Remaining Contractual Life (Years)	'4 years 36 days
OPTIONS OUTSTANDING - Weighted-Average Exercise Price	$1.01
OPTIONS EXERCISABLE - Options (in Shares)	74
OPTIONS EXERCISABLE - Weighted-Average Remaining Contractual Life (Years)	'4 years 36 days
OPTIONS EXERCISABLE - Weighted-Average Exercise Price	$1.01
Option Exercise Price $1.10 [Member]	'
5. Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]	'
Exercise Price Range	$1.10
OPTIONS OUTSTANDING - Options (in Shares)	100
OPTIONS OUTSTANDING - Weighted-Average Remaining Contractual Life (Years)	'4 years 3 months
OPTIONS OUTSTANDING - Weighted-Average Exercise Price	$1.10
OPTIONS EXERCISABLE - Options (in Shares)	75
OPTIONS EXERCISABLE - Weighted-Average Remaining Contractual Life (Years)	'4 years 3 months
OPTIONS EXERCISABLE - Weighted-Average Exercise Price	$1.10
Option Exercise Price $1.21 [Member]	'
5. Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]	'
Exercise Price Range	$1.21
OPTIONS OUTSTANDING - Options (in Shares)	50
OPTIONS OUTSTANDING - Weighted-Average Remaining Contractual Life (Years)	'4 years 3 months
OPTIONS OUTSTANDING - Weighted-Average Exercise Price	$1.21
OPTIONS EXERCISABLE - Options (in Shares)	38
OPTIONS EXERCISABLE - Weighted-Average Remaining Contractual Life (Years)	'4 years 3 months
OPTIONS EXERCISABLE - Weighted-Average Exercise Price	$1.21
Options Exercise Price $2.20 [Member]	'
5. Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]	'
Exercise Price Range	$2.20
OPTIONS OUTSTANDING - Options (in Shares)	164
OPTIONS OUTSTANDING - Weighted-Average Remaining Contractual Life (Years)	'4 years 281 days
OPTIONS OUTSTANDING - Weighted-Average Exercise Price	$2.20
OPTIONS EXERCISABLE - Options (in Shares)	23
OPTIONS EXERCISABLE - Weighted-Average Remaining Contractual Life (Years)	'4 years 281 days
OPTIONS EXERCISABLE - Weighted-Average Exercise Price	$1.21
Options Exercise Price $2.42 [Member]	'
5. Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]	'
Exercise Price Range	$2.42
OPTIONS OUTSTANDING - Options (in Shares)	10
OPTIONS OUTSTANDING - Weighted-Average Remaining Contractual Life (Years)	'4 years 281 days
OPTIONS OUTSTANDING - Weighted-Average Exercise Price	$2.42
OPTIONS EXERCISABLE - Options (in Shares)	2
OPTIONS EXERCISABLE - Weighted-Average Remaining Contractual Life (Years)	'4 years 281 days
OPTIONS EXERCISABLE - Weighted-Average Exercise Price	$1.21
Options Exercise Price $7.00 [Member]	'
5. Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]	'
Exercise Price Range	$7
OPTIONS OUTSTANDING - Options (in Shares)	1
OPTIONS OUTSTANDING - Weighted-Average Remaining Contractual Life (Years)	'1 year 120 days
OPTIONS OUTSTANDING - Weighted-Average Exercise Price	$7
OPTIONS EXERCISABLE - Options (in Shares)	1
OPTIONS EXERCISABLE - Weighted-Average Remaining Contractual Life (Years)	'1 year 120 days
OPTIONS EXERCISABLE - Weighted-Average Exercise Price	$7
Options Exercise Price $8.00 [Member]	'
5. Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]	'
Exercise Price Range	$8
OPTIONS OUTSTANDING - Options (in Shares)	5
OPTIONS OUTSTANDING - Weighted-Average Remaining Contractual Life (Years)	'1 year 335 days
OPTIONS OUTSTANDING - Weighted-Average Exercise Price	$8
OPTIONS EXERCISABLE - Options (in Shares)	5
OPTIONS EXERCISABLE - Weighted-Average Remaining Contractual Life (Years)	'1 year 335 days
OPTIONS EXERCISABLE - Weighted-Average Exercise Price	$8
Options Exercise Price $12.00 [Member]	'
5. Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]	'
Exercise Price Range	$12
OPTIONS OUTSTANDING - Options (in Shares)	1
OPTIONS OUTSTANDING - Weighted-Average Remaining Contractual Life (Years)	'219 days
OPTIONS OUTSTANDING - Weighted-Average Exercise Price	$12
OPTIONS EXERCISABLE - Options (in Shares)	1
OPTIONS EXERCISABLE - Weighted-Average Remaining Contractual Life (Years)	'219 days
OPTIONS EXERCISABLE - Weighted-Average Exercise Price	$12
Options Exercise Price $13.00 [Member]	'
5. Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]	'
Exercise Price Range	$13
OPTIONS OUTSTANDING - Options (in Shares)	1
OPTIONS OUTSTANDING - Weighted-Average Remaining Contractual Life (Years)	'222 days
OPTIONS OUTSTANDING - Weighted-Average Exercise Price	$13
OPTIONS EXERCISABLE - Options (in Shares)	1
OPTIONS EXERCISABLE - Weighted-Average Remaining Contractual Life (Years)	'222 days
OPTIONS EXERCISABLE - Weighted-Average Exercise Price	$13
Options Exercise Price $14.00 [Member]	'
5. Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]	'
Exercise Price Range	$14
OPTIONS OUTSTANDING - Options (in Shares)	0
OPTIONS OUTSTANDING - Weighted-Average Remaining Contractual Life (Years)	'1 year 171 days
OPTIONS OUTSTANDING - Weighted-Average Exercise Price	$14
OPTIONS EXERCISABLE - Options (in Shares)	0
OPTIONS EXERCISABLE - Weighted-Average Remaining Contractual Life (Years)	'1 year 171 days
OPTIONS EXERCISABLE - Weighted-Average Exercise Price	$14
Options Exercise Price $18.00 [Member]	'
5. Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]	'
Exercise Price Range	$18
OPTIONS OUTSTANDING - Options (in Shares)	5
OPTIONS OUTSTANDING - Weighted-Average Remaining Contractual Life (Years)	'62 days
OPTIONS OUTSTANDING - Weighted-Average Exercise Price	$18
OPTIONS EXERCISABLE - Options (in Shares)	5
OPTIONS EXERCISABLE - Weighted-Average Remaining Contractual Life (Years)	'62 days
OPTIONS EXERCISABLE - Weighted-Average Exercise Price	$18
Options Exercise Price $20.00 [Member]	'
5. Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]	'
Exercise Price Range	$20
OPTIONS OUTSTANDING - Options (in Shares)	0
OPTIONS OUTSTANDING - Weighted-Average Remaining Contractual Life (Years)	'1 year
OPTIONS OUTSTANDING - Weighted-Average Exercise Price	$20
OPTIONS EXERCISABLE - Options (in Shares)	0
OPTIONS EXERCISABLE - Weighted-Average Remaining Contractual Life (Years)	'1 year
OPTIONS EXERCISABLE - Weighted-Average Exercise Price	$20

6_Income_Taxes_Details

6. Income Taxes (Details)	Dec. 31, 2013	Mar. 31, 2013
Income Tax Disclosure [Abstract]	'	'
Valuation allowance, percentage	100.00%	100.00%

8_Stockholders_Equity_Details

8. Stockholders' Equity (Details)	9 Months Ended	12 Months Ended
	Dec. 31, 2013	Mar. 31, 2013
Stockholders' Equity Note [Abstract]	'	'
Stockholders' Equity, Reverse Stock Split	'	'1-for-100
Warrants, Description of Warrants	'issued a warrant that entitles, but not obligate Scotts Miracle-Gro to purchase a number of shares of common stock that, on a fully diluted basis, constitute 80% of the Company's outstanding capital stock.	'

8_Stockholders_Equity_Details_

8. Stockholders' Equity (Details) - Schedule of Stockholders' Equity Note, Warrants or Rights (USD $)	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Mar. 31, 2013
Share data in Thousands, except Per Share data, unless otherwise specified		Warrants Outstanding [Member]	Weighted Average Exercise Price [Member]	Aggregate Intrinsic Value [Member]	Aggregate Intrinsic Value [Member]
Class of Warrant or Right [Line Items]	'	'	'	'	'
Outstanding, April 1, 2013	703	528	'	'	'
Outstanding, April 1, 2013 (in Dollars per share)	$17.22	'	$22.41	'	'
Outstanding, April 1, 2013 (in Dollars)	'	'	'	$0	$0
Granted	'	175	'	'	'
Granted (in Dollars per share)	'	'	$1.70	'	'
Exercised	'	0	'	'	'
Exercised (in Dollars per share)	'	'	$0	'	'
Expired	'	0	'	'	'
Expired (in Dollars per share)	'	'	$0.98	'	'
Outstanding, December 31, 2013	703	703	'	'	'
Outstanding, December 31, 2013 (in Dollars per share)	$17.22	'	$17.22	'	'
Outstanding, December 31, 2013 (in Dollars)	'	'	'	$0	$0

8_Stockholders_Equity_Details_1

8. Stockholders' Equity (Details) - Schedule of Warrants Outstanding (USD $)	Dec. 31, 2013
In Thousands, except Per Share data, unless otherwise specified
8. Stockholders' Equity (Details) - Schedule of Warrants Outstanding [Line Items]	'
Warrants Outstanding	703
Weighted Average Exercise Price (in Dollars per share)	$17.22
Weighted Average Remaing Life (Yrs)	'3 years 69 days
Warrants exercisable at $1.54 [Member]	'
8. Stockholders' Equity (Details) - Schedule of Warrants Outstanding [Line Items]	'
Warrants Outstanding	125
Weighted Average Exercise Price (in Dollars per share)	$1.54
Weighted Average Remaing Life (Yrs)	'4 years 113 days
Warrants Exercisable at $2.10 [Member]	'
8. Stockholders' Equity (Details) - Schedule of Warrants Outstanding [Line Items]	'
Warrants Outstanding	50
Weighted Average Exercise Price (in Dollars per share)	$2.10
Weighted Average Remaing Life (Yrs)	'4 years 281 days
Warrants Exercisable at $7.00 [Member]	'
8. Stockholders' Equity (Details) - Schedule of Warrants Outstanding [Line Items]	'
Warrants Outstanding	394
Weighted Average Exercise Price (in Dollars per share)	$7
Weighted Average Remaing Life (Yrs)	'3 years 102 days
Warrants exercisable at $20.00 [Member]	'
8. Stockholders' Equity (Details) - Schedule of Warrants Outstanding [Line Items]	'
Warrants Outstanding	122
Weighted Average Exercise Price (in Dollars per share)	$20
Weighted Average Remaing Life (Yrs)	'1 year 135 days
Warrants Exercisable at $25.00 [Member]	'
8. Stockholders' Equity (Details) - Schedule of Warrants Outstanding [Line Items]	'
Warrants Outstanding	1
Weighted Average Exercise Price (in Dollars per share)	$25
Weighted Average Remaing Life (Yrs)	'281 days
Warrants exercisable at $100.00 [Member]	'
8. Stockholders' Equity (Details) - Schedule of Warrants Outstanding [Line Items]	'
Warrants Outstanding	3
Weighted Average Exercise Price (in Dollars per share)	$100
Weighted Average Remaing Life (Yrs)	'47 days
Warrants exercisable at $800.00 [Member]	'
8. Stockholders' Equity (Details) - Schedule of Warrants Outstanding [Line Items]	'
Warrants Outstanding	7
Weighted Average Exercise Price (in Dollars per share)	$800
Weighted Average Remaing Life (Yrs)	'248 days
Warrants exercisable at $825.00 [Member]	'
8. Stockholders' Equity (Details) - Schedule of Warrants Outstanding [Line Items]	'
Warrants Outstanding	1
Weighted Average Exercise Price (in Dollars per share)	$825
Weighted Average Remaing Life (Yrs)	'248 days